Clinical trial

GPX-100 in Treating Patients With Solid Tumors

NCT00003403

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1999-08-01

PhasePHASE1

Study timeline

Study start (unknown)1999-08-01Date precision: month

Registry last updated2013-04-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Interventions

GPX-100DRUG

Sponsors & collaborators

Gem Pharmaceuticalslead sponsor

Mapped research locations

JacksonvilleFlorida, United States1 Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003403 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.